Lang, D.; Brauner, A.; Huemer, F.; Rinnerthaler, G.; Horner, A.; Wass, R.; Brehm, E.; Kaiser, B.; Greil, R.; Lamprecht, B.
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study. Cancers 2022, 14, 93.
https://doi.org/10.3390/cancers14010093
AMA Style
Lang D, Brauner A, Huemer F, Rinnerthaler G, Horner A, Wass R, Brehm E, Kaiser B, Greil R, Lamprecht B.
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study. Cancers. 2022; 14(1):93.
https://doi.org/10.3390/cancers14010093
Chicago/Turabian Style
Lang, David, Anna Brauner, Florian Huemer, Gabriel Rinnerthaler, Andreas Horner, Romana Wass, Elmar Brehm, Bernhard Kaiser, Richard Greil, and Bernd Lamprecht.
2022. "Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study" Cancers 14, no. 1: 93.
https://doi.org/10.3390/cancers14010093
APA Style
Lang, D., Brauner, A., Huemer, F., Rinnerthaler, G., Horner, A., Wass, R., Brehm, E., Kaiser, B., Greil, R., & Lamprecht, B.
(2022). Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study. Cancers, 14(1), 93.
https://doi.org/10.3390/cancers14010093